Literature DB >> 1776548

Methodological note: corroboration of self-reported smoking status using significant other reports.

S L Emont1, R L Collins, W H Zywiak.   

Abstract

Significant other reports (SORs) are commonly used in smoking cessation studies to verify self-reports of smoking status. This report focuses on factors related to the smoker and significant other, which can affect self-reported classification of smoking status when using SORs. Data used in this analysis were collected from a cohort of 107 smokers who participated in a smoking cessation program. Participants were contacted at 1, 3, and 6 months after quitting to obtain self-reports of smoking status. SORs also were obtained at each assessment period. The highest discrepancy rate between self-report and SOR was observed among slippers, followed by relapsers, and abstainers, respectively. In addition, corroboration of smoking status was influenced by the social context in which the significant other was likely to see the smoker.

Entities:  

Mesh:

Year:  1991        PMID: 1776548     DOI: 10.1016/0306-4603(91)90025-d

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  3 in total

1.  Feasibility of biochemical verification in a web-based smoking cessation study.

Authors:  Sarah Cha; Ollie Ganz; Amy M Cohn; Sarah J Ehlke; Amanda L Graham
Journal:  Addict Behav       Date:  2017-05-22       Impact factor: 3.913

2.  A preliminary randomized controlled trial of a behavioral exercise intervention for smoking cessation.

Authors:  Ana M Abrantes; Erika Litvin Bloom; David R Strong; Deborah Riebe; Bess H Marcus; Julie Desaulniers; Kathryn Fokas; Richard A Brown
Journal:  Nicotine Tob Res       Date:  2014-05-08       Impact factor: 4.244

3.  Pilot RCT results of stop my smoking USA: a text messaging-based smoking cessation program for young adults.

Authors:  Michele L Ybarra; Jodi Summers Holtrop; Tonya L Prescott; Mohammad H Rahbar; David Strong
Journal:  Nicotine Tob Res       Date:  2013-01-24       Impact factor: 4.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.